+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Schizophrenia and cancer risk: can the CCR5-delta 32 chemokine receptor gene mutation play a role?



Schizophrenia and cancer risk: can the CCR5-delta 32 chemokine receptor gene mutation play a role?



Medical Hypotheses 67(2): 427-428




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 050258445

Download citation: RISBibTeXText

PMID: 16644139

DOI: 10.1016/j.mehy.2006.03.008


Related references

Frequency of the CCR5-delta 32 chemokine receptor gene mutation in the Lebanese population. Eastern Mediterranean Health Journal 10(4-5): 671-675, 2005

Controversial role of smallpox on historical positive selection at the CCR5 chemokine gene (CCR5-Delta 32). Journal of Infection in Developing Countries 3(4): 324-326, 2009

Distribution of human chemokine (C-X3-C) receptor 1 (CX3CR1) gene polymorphisms and haplotypes of the CC chemokine receptor 5 (CCR5) promoter in Chinese people, and the effects of CCR5 haplotypes on CCR5 expression. International Journal of Immunogenetics 32(2): 99-106, 2005

The chemokine receptor CCR5-Delta32 gene mutation is not protective against Alzheimer's disease. Neuroscience Letters 366(3): 312-314, 2004

Prevalence of the chemokine receptor CCR5-Delta32 gene mutation in periodontal disease. Clinical Immunology 109(3): 325-329, 2003

Chemokine Ligand 5 (CCL5) and chemokine receptor (CCR5) genetic variants and prostate cancer risk among men of African Descent: a case-control study. Hereditary Cancer in Clinical Practice 10(1): 16-16, 2012

Effects of CC chemokine receptor 5 (CCR5) inhibitors on the dynamics of CCR5 and CC-chemokine-CCR5 interactions. Antiviral Therapy 15(3): 321-331, 2010

Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele. Emerging Infectious Diseases 3(3): 261-271, 1997

Concerns related to CCR5 gene delta 32 mutation role in hepatitis B virus infection. Przeglad Epidemiologiczny 71(4): 571-581, 2018

Delta 32 mutation of the chemokine-receptor 5 gene in inflammatory bowel disease. Clinical Immunology 98(1): 18-22, 2001

Role of CCR5 chemokine receptor gene in vertical human immunodeficiency virus type 1 transmission and disease progression. Pediatric Infectious Disease Journal 17(9): 847-849, 1998

A novel chemokine-receptor-5 (CCR5) blocker, SCH532706, has differential effects on CCR5+CD4+ and CCR5+CD8+ T cell numbers in chronic HIV infection. Aids Research and Human Retroviruses 26(6): 653-661, 2010

The chemokine receptor CCR5 deletion mutation is associated with MS in HLA-DR4-positive Russians. Neurology 59(10): 1652-1655, 2002

No association between common chemokine and chemokine receptor gene variants and prostate cancer risk. Cancer Epidemiology, Biomarkers & Prevention 17(12): 3615-3617, 2008

Analysis of the CC chemokine receptor 5 (CCR5) delta-32 polymorphism in inflammatory bowel disease. Human Genetics 108(3): 190-193, 2001